• EyeXchange Solutions connects experienced and emerging surgeons across cataract, glaucoma, and retina specialties to share insights, refine techniques, and address complex cases.

• BVI Medical aims to facilitate a collaborative forum fostering learning in ophthalmology through video series, engaging email discussions, and interactive quizzes.

Waltham, MA, January 31st, 2024 – BVI Medical, a diversified global ophthalmic device company committed to advancing eye surgery and improving patients’ vision, is excited to introduce EyeXchange Solutions. This new platform is designed to advance vision care through a comprehensive program of educational resources and clinical support, empowering surgical decisions, enhancing provider experiences, reducing the economic burden on healthcare systems, and optimizing patient care in cataract, glaucoma, and retina specialties.

In an ever-evolving field, EyeXchange Solutions facilitates insights to surgeons to navigate complex cases, refine techniques, and engage in meaningful discussions about the future of ophthalmology. By connecting experienced professionals with younger generations of surgeons, the platform fosters a continuous exchange of perspectives and practical skills.

Platform’s Core Tenets

• Education & Support: Dedicated to continuous learning through peer-to-peer education (in person or on demand), case studies, interactive surveys, and both didactic and hands-on clinical experiences.

• Patient-Centricity: Focused on improving patient outcomes by addressing the challenges and complexities inherent in vision care.

• Knowledge Sharing: Promotes collaboration, through a central intelligence hub.

“EyeXchange Solutions is about creating conversations that matter—bringing people together to share insights and learn from one another’s experiences. At BVI Medical, we are committed to being a trusted thought partner in addressing the complexities of modern ophthalmic care,” said Aimee Shimamoto, Vice President, Co-Head Global Marketing at BVI Medical.

Key Features

• EyeXchange Talks: Video series hosted on EyeXchange Solutions’ official website or presented live at major events, moderated by respected leaders in the field.

• Physician Perspectives: Thought-provoking questions sent via email each month to encourage discussion and share insights.

• Interactive Quiz: Engaging quizzes offering participants the opportunity to expand their knowledge and apply new concepts in their practice.

Through this new platform, BVI Medical reaffirms its dedication to fostering meaningful dialogue within the ophthalmology community. EyeXchange Solutions aligns with the company’s mission to support professionals navigating complex cases while providing valuable insights into perioperative, procedural, and business practices.

To learn more and join the conversation, visit https://eyexchange.bvimedical.com/

***

About BVI Medical

BVI® is a diversified global ophthalmic device company with a mission to deliver high-quality solutions and innovation for advancing eye surgery and improving patients’ vision. With nine decades of developing leading products and solutions, BVI partners with ophthalmic surgeons to improve the vision of millions of patients across the globe. Our organization supports surgical teams in more than 90 countries worldwide, either directly or through our network of trusted distributors.

Press Contact

David Chavez, Global Communications Lead

[email protected] 

+1 (857) 869 8706

WALTHAM, Mass., Sept. 15, 2022 (GLOBE NEWSWIRE) — BVI, a diversified global ophthalmic device company, today announced certification for its intraocular lens (IOL) portfolio under the European Medical Device Regulation (MDR, (EU) 2017/745) from its Notified Body, the British Standards Institution (BSI)¹. The new regulatory criteria came into effect in May 2021, replacing the prior Medical Device Directive (MDD).

The MDR, representing the most significant change to European regulatory framework in decades, ensures a consistently high level of health and safety for medical devices. The new provisions focus on:

• Strict requirements with the intention to prove the safety of medical devices for both users and patients;
• Increased transparency of clinical evaluation, post market surveillance, and clinical investigation that needs to be up to date, clear, convincing, and publicly available;
• Greater emphasis on detailed requirements for technical documentation;
• Increased control and monitoring by national competent authorities and the EC;
• Reclassification of devices, wider scope of devices; and
• New Unique Device Identification system with enhanced traceability and post-market surveillance.

“Achieving and maintaining MDR certification is a major effort that requires a tremendous amount of investment, capabilities, and hard work,” said Shervin Korangy, BVI President and CEO. “This important milestone ensures continued supply of our innovative and clinically differentiated IOLS to our surgeons and patients worldwide.”

BVI Senior Vice President, Business Operations and Quality Assurance, Devang Shah, Ph.D. added, “We are proud to have obtained this certification, in partnership with our Notified Body BSI, which confirms BVI’s commitment to quality and compliance to the highest of regulatory standards. A recent MedTech report highlighted that Notified Bodies have yet to issue MDR certificates for more than 85% of the products certified under the prior directives² – so being at the forefront of this is a testament to our team’s expertise and dedication to our customers.”

About BVI

BVI^® is a diversified global ophthalmic device company with a mission to deliver high quality solutions and innovation for advancing eye surgery and improving the vision of patients. With nine decades of developing leading products and solutions, BVI partners with ophthalmic surgeons to improve the vision of millions of patients across the globe. Our organization supports surgical teams in more than 90 countries worldwide, either directly or through our network of trusted distributors. Our trusted brands include: Beaver^® (Knives and Blades), Visitec^® (Cannulas), Malosa^® (Single-Use Instruments), Vitreq^® (Vitreoretinal Surgical Products) and PhysIOL^® (Premium IOLs).

1. BSI Client Directory Profile: https://www.bsigroup.com/en-GB/validate-bsi-issued-certificates/client-directory-profile/PHYSIO-0047610705-000
2. https://www.medtechdive.com/news/legacy-devices-lack-mdr-certificates-medtech-europe/627439/